M2Bio (OTC: $WUHN) Adds Liviana a Functional Food Brand to Portfolio

m2bio-sciences-$wuhn-olive-oil-liviana-internet-bull-report

M2Bio Sciences (OTC: $WUHN) adds Liviana Extra Virgin Olive Oil, a functional food brand to their portfolio of CBD-infused products.

This time it’s a Mediterranean favorite: Olive Oil.

Olive oil is healthy in so many different ways, and with infused CBD it doesn’t get much better. Functional foods are on the rise and M2Bio Sciences delivers on what the consumers want.

Interest in the Mediterranean diet began in the 1960s with the observation that coronary heart disease caused fewer deaths in Mediterranean countries, such as Greece and Italy, than in the U.S. and northern Europe.

The foundation of the Mediterranean diet is plant-based, not meat-based, and relies on high-quality ingredients. That is exactly the combination of health and high-quality products the firm behind the brand seeks to achieve. “CBD seems to be pretty good for anti-inflammatory, may have some anti-pain (properties), and it certainly has some effect on mood,” says Dr. Bauer, Mayo Clinic.

“… I had no idea the science behind CBD is so fascinating and compelling. In addition, [M2Bio cares] deeply about delivering a premium product to consumers which hugely resonated with Chaloner.” – Perry Chaloner, Chaloner Estates MD.

 

 

 

Read the full press release here:


Wuhan General Group Introduces Liviana™ CBD Infused Artisanal Olive Oil

Friday, April 9, 2021, 11:25 AM

CAPE TOWN, SA / ACCESSWIRE / April 9, 2021 / WUHAN GENERAL GROUP, INC. (OTC:WUHN) (“Wuhan” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update regarding its latest brand offering:

liviana-oilve-oil-cbd-medical-cannabis-interenet-bull-report

We are thrilled to introduce our upcoming brand LivianaTM which is set to launch in May 2021. The LivianaTM brand will kick off its product line with a range of three spectacular CBD infused olive oils:

  • The Estate Extra Virgin Olive Oil (EVOO);
  • The Three Chili-Infused EVOO;
  • The Natural Lemon-Infused EVOO.

These remarkable olive oils will be bottled at source from the Falcon’s Nest Farm owned by Chaloner Estates which is beautifully nestled on the Stellenbosch Mountains slopes, Cape Town, South Africa. The olive oils produced by the Chaloner team have won multiple awards for their exceptional quality. The new LivianaTMformulations have passed the final taste test and will be available in the markets very soon.

It’s been great fun and educational to work with Jeff and the M2BIO Sciences team in developing the three variants. I had no idea the science behind CBD is so fascinating and compelling. In addition, they care deeply about delivering a premium product to consumers which hugely resonated with Chaloner. We look forward to furthering unique collaborations in the near future. ” said Perry Chaloner, Chaloner Estates Managing Director.

There is a plethora of great science that shows the enormous benefits for those that follow the Mediterranean Diet versus those that don’t. Olive oil consumption is a big part of the diet. Introducing a CBD infusion into the olive oil gives it a one-two knock-out punch that makes for an exceptionally healthy product. And the flavors? Heaven-sent. ” said Jeff Robinson Wuhan General Group CEO.

LivianaTM olive oils have no added artificial flavorings, colors or MSG and will be produced, bottled and packaged in a sustainable and conscientious manner. The Wuhan and Chaloner teams are united by their dedication to doing their part in helping make the planet a better, safer and cleaner place, one day at a time.

About Wuhan General Group, Inc./ M2Bio Sciences, Inc

Wuhan General Group, Inc. through its wholly owned subsidiary MJ MedTech is a nutraceutical biotechnology company that researches, develops and commercializes a range of CBD-based products under Dr. AnnaRx™, Medspresso™, LivianaTM and Handcrafted Delights™ brands. In addition, its wholly owned division, M2Bio is researching and developing indications for psilocybin new therapies that will help patients who suffer from addiction, mental illness, Alzheimer’s and Parkinson’s. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research and emerging technologies. Wuhan is listed and traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol “WUHN”.

 

Avatar
Luka Marjanovic

Partner

Luka holds a Bachelor’s in International Business and a Master’s in International Management. During his undergraduate studies he worked as a research assistant in the field of Big Data; founded his own consulting firm providing services to local SME's in various sectors and invested in the capital markets; as well as working pro-bono providing education and career counselling. Prior to his business education, he studied Biology-and-Biotechnology, and served in the Danish Royal Army as Second Sergeant, leading and managing a group under extreme conditions and pressure. Luka has spent significant time abroad, living and working in seven different countries. When he's not in the office, he's chasing the next gusts windsurfing, carving the mountain snowboarding or out in the forest for a jog.